Announced Wed, 17 Jun · 13:38 IST
Vivimed Labs publishes Form G for CIRP resolution applicants
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹6.21
prior close
₹6.19
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-1.5-1.5-3.9-2.4-5.0-5.0-5.0-5.5-3.5-10.6-15.6——
Up moveDown movePending
AI summary
Vivimed Labs published Form G dated June 14, 2026 inviting expression of interest from resolution applicants under CIRP. The pharma dosage maker has units in Hyderabad, Uttarakhand and Bidar. Revenue fell from INR 136.8 Crore in FY24 to INR 103.6 Crore in FY25. Interim Resolution Professional T Narayana Swamy is handling the process. Last date for EOI is June 29 and resolution plans by August 28, 2026.
Likely market impact
Highly negative for shareholders. Under CIRP, creditors get priority and existing equity is likely to be heavily diluted or wiped out in resolution.